Lebwohl M, Armstrong AW, Merola JF, Gottlieb AB, Davis L, Gomez B, Wiegratz S, Cross N, Strober B. Bimekizumab efficacy through one year in patients with moderate to severe plaque psoriasis in subgroups defined by prior biologic treatment: Pooled results from four phase 3/3b trials . J of Skin [Internet]. 2022 Nov. 16 [cited 2024 Jul. 3];6(6):s64. Available from: https://jofskin.org/33014/index.php/skin/article/view/1819